Clinical Trial Update: Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 update describes the dose-escalation and expansion study of AROG4-01 in patients with advanced solid tumors, including mesothelioma, colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Mesothelioma
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• AROG4-01

Snippet

Sponsor: Aromics Therapeutics | Conditions: Solid Tumors (Phase 1), Mesothelioma | Phase 1 | Status: NOT_YET_RECRUITING